Publications by authors named "Sebastien Apcher"

22Publications

Tumors escape immunosurveillance by overexpressing the proteasome activator PSME3.

Oncoimmunology 2020 May 21;9(1):1761205. Epub 2020 May 21.

Immunologie des Tumeurs et Immunothérapie, Université Paris-Saclay, Institut Gustave Roussy, Inserm, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2020.1761205DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458623PMC
May 2020

The source of MHC class I presented peptides and its implications.

Curr Opin Immunol 2016 06 19;40:117-22. Epub 2016 Apr 19.

Equipe Labellisée la Ligue Contre le Cancer, Inserm UMR1162, Université Paris 7, Institut de Génétique Moléculaire, 27 rue Juliette Dodu, 75010 Paris, France; RECAMO, Masaryk Memorial Cancer Institute, Zluty kopec 7, 656 53 Brno, Czech Republic; Department of Medical Biosciences, Umeå University, SE-90185 Umeå, Sweden. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.coi.2016.04.002DOI Listing
June 2016

Pioneer translation products as an alternative source for MHC-I antigenic peptides.

Mol Immunol 2015 Dec 12;68(2 Pt A):68-71. Epub 2015 May 12.

Equipe Labellisée la Ligue Contre le Cancer, Inserm UMR1162, Université Paris 7, Institut de Génétique Moléculaire, 27 rue Juliette Dodu, 75010 Paris, France; RECAMO, Masaryk Memorial Cancer Institute, Zluty kopec 7, 656 53 Brno, Czech Republic. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molimm.2015.04.019DOI Listing
December 2015

[Synthesis of MHC class I antigenic peptides in the nucleus: a role for the nuclear translation at last?].

Med Sci (Paris) 2014 Mar 31;30(3):229-31. Epub 2014 Mar 31.

Institut Gustave Roussy, Université Paris Sud, département d'immunologie, Unité 1015, 114, rue Édouard Vaillant, 94805 Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1051/medsci/20143003002DOI Listing
March 2014

A yeast-based assay identifies drugs that interfere with immune evasion of the Epstein-Barr virus.

Dis Model Mech 2014 Apr 20;7(4):435-44. Epub 2014 Feb 20.

Institut National de la Santé et de la Recherche Médicale UMR 1078; Université de Bretagne Occidentale, Faculté de Médecine et des Sciences de la Santé; Etablissement Français du Sang (EFS) Bretagne; CHRU Brest, Hôpital Morvan, Laboratoire de Génétique Moléculaire, Brest F-29200, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1242/dmm.014308DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3974454PMC
April 2014

Translation of pre-spliced RNAs in the nuclear compartment generates peptides for the MHC class I pathway.

Proc Natl Acad Sci U S A 2013 Oct 30;110(44):17951-6. Epub 2013 Sep 30.

Cibles Thérapeutiques, Equipe Labellisé la Ligue Contre le Cancer, Institut National de la Santé et de la Recherche Médicale, Unité Mixte de Recherche 940, Institut de Génétique Moléculaire, Hôpital St. Louis, Université Paris 7, F-75010 Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1309956110DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816435PMC
October 2013

The role of mRNA translation in direct MHC class I antigen presentation.

Curr Opin Immunol 2012 Feb;24(1):71-6

Cibles Therapeutiques, INSERM UMRS940, Institut de Génétique Moléculaire, Université Paris 7, Hôpital St. Louis, 27 rue Juliette Dodu, 75010 Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.coi.2012.01.007DOI Listing
February 2012

Beyond the classical: influenza virus and the elucidation of alternative MHC class II-restricted antigen processing pathways.

Immunol Res 2011 Dec;51(2-3):237-48

Department of Microbiology and Immunology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12026-011-8257-3DOI Listing
December 2011

Major source of antigenic peptides for the MHC class I pathway is produced during the pioneer round of mRNA translation.

Proc Natl Acad Sci U S A 2011 Jul 27;108(28):11572-7. Epub 2011 Jun 27.

Cibles Therapeutiques, Institut National de la Santé et de la Recherche Médicale U940, Institut de Génétique Moléculaire, Université Paris 7, Hôpital St. Louis, 75010 Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1104104108DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3136330PMC
July 2011

Epstein Barr virus-encoded EBNA1 interference with MHC class I antigen presentation reveals a close correlation between mRNA translation initiation and antigen presentation.

PLoS Pathog 2010 Oct 14;6(10):e1001151. Epub 2010 Oct 14.

Cibles Thérapeutiques, INSERM U940, Institut de Génétique Moléculaire, Université Paris 7, Hôpital St. Louis, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.ppat.1001151DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2954899PMC
October 2010

The cell-penetrating peptide octa-arginine is a potent inhibitor of proteasome activities.

Eur J Pharm Biopharm 2009 May 7;72(1):219-25. Epub 2008 Nov 7.

Institut für Biochemie/CCM, Charité-Universitätsmedizin-Berlin, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejpb.2008.10.016DOI Listing
May 2009

mRNA translation regulation by the Gly-Ala repeat of Epstein-Barr virus nuclear antigen 1.

J Virol 2009 Feb 19;83(3):1289-98. Epub 2008 Nov 19.

INSERM Unité 716, Institut de Génétique Moléculaire, Université Paris 7, Hôpital St. Louis, 27 rue Juliette Dodu, 75010 Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/JVI.01369-08DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2620890PMC
February 2009

Gly-Ala repeats induce position- and substrate-specific regulation of 26 S proteasome-dependent partial processing.

J Biol Chem 2008 Oct 29;283(44):30090-100. Epub 2008 Aug 29.

INSERM U716, Institut de Génétique Moléculaire, Université Paris 7, Hôpital St. Louis, 75010 Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M803290200DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2662073PMC
October 2008

Epstein-Barr virus: exploiting the immune system by interfering with defective ribosomal products.

Microbes Infect 2004 Nov;6(13):1212-8

Institut de Pharmacologie, EPI0334 Hôpital St Louis, 27, rue Juliette-Dodu 75010, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.micinf.2004.08.003DOI Listing
November 2004

Human immunodeficiency virus-1 Tat protein interacts with distinct proteasomal alpha and beta subunits.

FEBS Lett 2003 Oct;553(1-2):200-4

Humboldt Universität zu Berlin, Universitätsklinikum Charité, Institut für Biochemie, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0014-5793(03)01025-1DOI Listing
October 2003

Gankyrin is an ankyrin-repeat oncoprotein that interacts with CDK4 kinase and the S6 ATPase of the 26 S proteasome.

J Biol Chem 2002 Mar 4;277(13):10893-902. Epub 2002 Jan 4.

Laboratory of Intracellular Proteolysis, School of Biomedical Sciences, University of Nottingham Medical School, Queen's Medical Centre, Nottingham NG7 2UH, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M107313200DOI Listing
March 2002